LONDON (Reuters) - Reckitt Benckiser (RB.L) said on Tuesday it looked forward to clinching a deal to buy U.S. vitamin maker Schiff Nutrition SHF.N after rival bidder Bayer (BAYGn.DE) announced it would not increase its offer.
Reckitt last week trumped Bayer’s $1.2 billion agreed deal to buy Schiff with a higher offer of $1.4 billion.
“Our original tender offer still stands and we look forward to reaching an agreement,” a spokeswoman for the UK consumer goods group said. “We are in communication with them (Schiff),” she added, while declining to go into further details.
Reporting by Ben Hirschler; editing by Andrew Callus